CardiNor AS

CardiNor AS is a Norwegian diagnostic company founded in 2015 to handle the assay development and commercialization of the cardiac biomarker secretoneurin (SN). SN addresses a medical unmet need by providing prognostic insight and risk stratification of patients with life threatening arrhythmias to aid in patient selection for ICD treatment (implantable cardioverter-defibrillator), and other cardiovascular diseases (CVD). The company has established an extensive network of Key Opinion Leaders (KOLs) in the field that has provided CardiNor with access to large international, renowned clinical cohorts for the documentation and validation of the SN ELISA assay. Supported by the Norwegian Research Council, CardiNor is on track with its bead-based SN assay for high throughput testing platforms. CardiNor is located in Oslo with an R&D department in Bodø, in northern Norway.